BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31700580)

  • 21. Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.
    Crowder SL; Douglas KG; Yanina Pepino M; Sarma KP; Arthur AE
    J Cancer Surviv; 2018 Aug; 12(4):479-494. PubMed ID: 29556926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Smoking Cessation and Continuation on Recurrence and Survival in Patients with Head and Neck Cancer: A Systematic Review of the Literature.
    von Kroge PR; Bokemeyer F; Ghandili S; Bokemeyer C; Seidel C
    Oncol Res Treat; 2020; 43(10):549-558. PubMed ID: 32950990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excessive inflammation portends complications: Wound cytokines and head and neck surgery outcomes.
    Lassig AAD; Lindgren BR; Itabiyi R; Joseph AM; Gupta K
    Laryngoscope; 2019 Jul; 129(7):E238-E246. PubMed ID: 30628094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research status and prospects of acupuncture for prevention and treatment of chemo- and radiotherapy-induced salivary gland dysfunction in head and neck cancer.
    Zhang SQ; Chen HB; Liu J; Dai WJ; Lu QQ; Li JC
    Anat Rec (Hoboken); 2021 Nov; 304(11):2381-2396. PubMed ID: 34626452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis.
    Rapado-González Ó; Martínez-Reglero C; Salgado-Barreira Á; Santos MA; López-López R; Díaz-Lagares Á; Suárez-Cunqueiro MM
    J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34206840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive function after (chemo)-radiotherapy for head and neck cancer.
    Welsh LC; Dunlop AW; McGovern T; McQuaid D; Dean JA; Gulliford SL; Bhide SA; Harrington KJ; Nutting CM; Newbold KL
    Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):765-75. PubMed ID: 25028338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth.
    Xiao N; Cao H; Chen CH; Kong CS; Ali R; Chan C; Sirjani D; Graves E; Koong A; Giaccia A; Mochly-Rosen D; Le QT
    Clin Cancer Res; 2013 Aug; 19(16):4455-64. PubMed ID: 23812668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation therapy quality assurance in head and neck radiotherapy - Moving forward.
    McDowell L; Corry J
    Oral Oncol; 2019 Jan; 88():180-185. PubMed ID: 30616792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers.
    Perry A; Lee SH; Cotton S; Kennedy C
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011112. PubMed ID: 27562477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary flow rate after conventional and intensity-modulated radiation therapy.
    Nguyen CT; Lin S; Clark H; Hovan A; Wu J
    J Am Dent Assoc; 2018 Jun; 149(6):432-441. PubMed ID: 29655708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients.
    Brzozowska A; Powrózek T; Homa-Mlak I; Mlak R; Ciesielka M; Gołębiowski P; Małecka-Massalska T
    Pathol Oncol Res; 2018 Jan; 24(1):135-143. PubMed ID: 28401452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
    Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
    Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical effectiveness and safety of acupuncture in the treatment of irradiation-induced xerostomia in patients with head and neck cancer: a systematic review.
    O'Sullivan EM; Higginson IJ
    Acupunct Med; 2010 Dec; 28(4):191-9. PubMed ID: 21062848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.
    Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I
    Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insufficient evidence for interventions to prevent dry mouth and salivary gland dysfunction post head and neck radiotherapy.
    Ferraiolo DM; Veitz-Keenan A
    Evid Based Dent; 2018 Mar; 19(1):30-31. PubMed ID: 29568026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Loimu V; Seppälä T; Kapanen M; Tuomikoski L; Nurmi H; Mäkitie A; Tenhunen M; Saarilahti K
    Radiother Oncol; 2017 Feb; 122(2):178-184. PubMed ID: 27475276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy for head and neck cancer in nonagenarian patients: a possible cornerstone?
    Rivoirard R; Moncharmont C; Assouline A; Auberdiac P; Mery B; Falk AT; Annède P; Trone JC; Guy JB; Vial N; Fournel P; Merrouche Y; Chargari C; Magné N
    Eur Arch Otorhinolaryngol; 2015 Mar; 272(3):719-25. PubMed ID: 24691850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of continued smoking in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis.
    Smith J; Nastasi D; Tso R; Vangaveti V; Renison B; Chilkuri M
    Radiother Oncol; 2019 Jun; 135():51-57. PubMed ID: 31015170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MUC5B levels in submandibular gland saliva of patients treated with radiotherapy for head-and-neck cancer: a pilot study.
    Dijkema T; Terhaard CH; Roesink JM; Raaijmakers CP; van den Keijbus PA; Brand HS; Veerman EC
    Radiat Oncol; 2012 Jun; 7():91. PubMed ID: 22704532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.